Literature DB >> 12500917

Factors associated with the high cost of liver transplantation in adults.

Mark C Taylor1, Paul D Greig, Allan S Detsky, Robin S McLeod, Ahmed Abdoh, Murray D Krahn.   

Abstract

OBJECTIVES: To determine the overall direct cost of liver transplantation in Canadian adults and to identify the factors that are associated with high cost.
METHODS: The direct cost of liver transplantation from the perspective of third-party payers was determined in a retrospective analysis of data from hospital charts and databases. A consecutive series of 119 adults who underwent liver transplantation between 1991 and 1992 was followed from the date of listing for transplantation to the second anniversary of the transplant. Patient-specific services during the pre-transplantation, transplantation and post-transplantation phases were compiled and costed. The primary consideration was the impact of complications on the cost of transplantation. Secondary considerations were the impact of age, sex of the patient, diagnosis and severity of liver disease on the total cost.
RESULTS: The overall mean measured cost of liver transplantation was Can$89,066 (range from Can$30,505-Can$690,431). The multivariate logistic regression model for overall costs revealed that severe liver disease (OR = 11.97), cytomegalovirus infection (OR = 6.12), additional operative procedure (OR = 4.22) and biliary complications (OR = 5.00) were associated with an increased likelihood of high cost. The addition of services that were not measured in the present analysis increased the total overall cost to a mean of $121,732 (1998 Canadian dollars, follow-up costs discounted and inflation adjusted).
INTERPRETATION: The factors that were associated with high cost of liver transplantation in Canadian adults were advanced liver disease, postoperative cytomegalovirus infection, the requirement for additional operative procedures and biliary complications.

Entities:  

Mesh:

Year:  2002        PMID: 12500917      PMCID: PMC3684657     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  14 in total

Review 1.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis.

Authors:  William W L Wong; Karen M Lee; Sumeet Singh; George Wells; Jordan J Feld; Murray Krahn
Journal:  CMAJ Open       Date:  2017-02-03

4.  Societal reintegration following cadaveric orthotopic liver transplantation.

Authors:  Ryan Kelly; Scott Hurton; Subhashini Ayloo; Mathew Cwinn; Sarah De Coutere-Bosse; Michele Molinari
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

5.  Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

Authors:  Leigh Anne Dageforde; Irene D Feurer; C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2012-07-04       Impact factor: 3.647

6.  Cost-utility analysis of nonalcoholic steatohepatitis screening.

Authors:  Eric Zhang; Claire Wartelle-Bladou; Luigi Lepanto; Jean Lachaine; Guy Cloutier; An Tang
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

Review 7.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

8.  The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.

Authors:  Paolo R Salvalaggio; Nino Dzebisashvili; Kara E MacLeod; Krista L Lentine; Adrian Gheorghian; Mark A Schnitzler; Samuel Hohmann; Dorry L Segev; Sommer E Gentry; David A Axelrod
Journal:  Liver Transpl       Date:  2011-03       Impact factor: 5.799

Review 9.  Burden of disease and cost of chronic hepatitis C infection in Canada.

Authors:  Robert P Myers; Mel Krajden; Marc Bilodeau; Kelly Kaita; Paul Marotta; Kevork Peltekian; Alnoor Ramji; Chris Estes; Homie Razavi; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

Review 10.  Signal transduction of platelet-induced liver regeneration and decrease of liver fibrosis.

Authors:  Soichiro Murata; Takehito Maruyama; Takeshi Nowatari; Kazuhiro Takahashi; Nobuhiro Ohkohchi
Journal:  Int J Mol Sci       Date:  2014-03-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.